CanSino Biologics Inc. (HKG: 6185)

CanSino Biologics Revenue

CanSino Biologics had revenue of 263.65M CNY in the quarter ending September 30, 2024, with 76.09% growth. This brings the company's revenue in the last twelve months to 748.53M, up 48.86% year-over-year. In the year 2023, CanSino Biologics had annual revenue of 357.08M, down -65.49%.

• Revenue (ttm): 748.53M CNY
• Revenue Growth: +48.86%
• P/S Ratio: 9.14
• Revenue / Employee: 501.02K CNY
• Employees: 1,494
• Market Cap: 11.32B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	357.08M	-677.51M	-65.49%
Dec 31, 2022	1.03B	-3.27B	-75.94%
Dec 31, 2021	4.30B	4.27B	17,174.82%
Dec 31, 2020	24.89M	22.61M	990.05%
Dec 31, 2019	2.28M	-6.37M	-73.62%